These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18361424)

  • 41. A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.
    Genro JP; Polanczyk GV; Zeni C; Oliveira AS; Roman T; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1568-75. PubMed ID: 18802919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.
    Zhai D; Li S; Zhao Y; Lin Z
    Neurosci Lett; 2014 Apr; 564():99-104. PubMed ID: 24211691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
    Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
    Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New genetic evidence for involvement of the dopamine system in migraine with aura.
    Todt U; Netzer C; Toliat M; Heinze A; Goebel I; Nürnberg P; Göbel H; Freudenberg J; Kubisch C
    Hum Genet; 2009 Apr; 125(3):265-79. PubMed ID: 19152006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium.
    van Munster BC; Yazdanpanah M; Tanck MW; de Rooij SE; van de Giessen E; Sijbrands EJ; Zwinderman AH; Korevaar JC
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):38-45. PubMed ID: 19309018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DRD4 and SLC6A3 gene polymorphisms are associated with food intake and nutritional status in children in early stages of development.
    Fontana C; Vitolo MR; Campagnolo PD; Mattevi VS; Genro JP; Almeida S
    J Nutr Biochem; 2015 Dec; 26(12):1607-12. PubMed ID: 26350252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder.
    Pinsonneault JK; Han DD; Burdick KE; Kataki M; Bertolino A; Malhotra AK; Gu HH; Sadee W
    Neuropsychopharmacology; 2011 Jul; 36(8):1644-55. PubMed ID: 21525861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association and linkage of allelic variants of the dopamine transporter gene in ADHD.
    Friedel S; Saar K; Sauer S; Dempfle A; Walitza S; Renner T; Romanos M; Freitag C; Seitz C; Palmason H; Scherag A; Windemuth-Kieselbach C; Schimmelmann BG; Wewetzer C; Meyer J; Warnke A; Lesch KP; Reinhardt R; Herpertz-Dahlmann B; Linder M; Hinney A; Remschmidt H; Schäfer H; Konrad K; Hübner N; Hebebrand J
    Mol Psychiatry; 2007 Oct; 12(10):923-33. PubMed ID: 17579611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children.
    Mick E; Wozniak J; Wilens TE; Biederman J; Faraone SV
    BMC Psychiatry; 2009 Feb; 9():2. PubMed ID: 19193231
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Liu K; Yu J; Zhao J; Zhou Y; Xiong N; Xu J; Wang T; Bell RL; Qing H; Lin Z
    Mol Neurobiol; 2018 Jul; 55(7):5611-5622. PubMed ID: 28983843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine transporter gene polymorphism in children with ADHD: A pilot study in Indonesian samples.
    Wiguna T; Ismail RI; Winarsih NS; Kaligis F; Hapsari A; Budiyanti L; Sekartini R; Rahayu S; Guerrero APS
    Asian J Psychiatr; 2017 Oct; 29():35-38. PubMed ID: 29061424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study.
    Kelada SN; Checkoway H; Kardia SL; Carlson CS; Costa-Mallen P; Eaton DL; Firestone J; Powers KM; Swanson PD; Franklin GM; Longstreth WT; Weller TS; Afsharinejad Z; Costa LG
    Hum Mol Genet; 2006 Oct; 15(20):3055-62. PubMed ID: 16963468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The VNTR polymorphism in the human dopamine transporter gene: improved detection and absence of association of VNTR alleles with attention-deficit hyperactivity disorder.
    Simsek M; Al-Sharbati M; Al-Adawi S; Lawatia K
    Genet Test; 2006; 10(1):31-4. PubMed ID: 16545000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria.
    Geller B; Tillman R
    J Clin Psychiatry; 2005; 66 Suppl 7():21-8. PubMed ID: 16124838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
    Shang CY; Gau SS; Liu CM; Hwu HG
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine transporter gene may be associated with bipolar disorder and its personality traits.
    Huang CC; Lu RB; Yen CH; Yeh YW; Chou HW; Kuo SC; Chen CY; Chang CC; Chang HA; Ho PS; Liang CS; Cheng S; Shih MC; Huang SY
    Eur Arch Psychiatry Clin Neurosci; 2015 Jun; 265(4):281-90. PubMed ID: 25547317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Family-based association study of early growth response gene 3 with child bipolar I disorder.
    Gallitano AL; Tillman R; Dinu V; Geller B
    J Affect Disord; 2012 May; 138(3):387-96. PubMed ID: 22370066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.